Ian Schlieder, DO
Vascular Surgery · Salt Lake City, UTNPI 1073956793
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,801 of the $2,506 with a category attached, or 71.9%. 8 manufacturers reported payments, led by Silk Road Medical, Inc. at 33.8% of the total. Reporting peaked in 2020 at $776 and has fallen 64.3% since, to $277 in 2025. That places this record below the midpoint for vascular surgery clinicians in UT, where the typical reported total is $2,506.
Across 37 payments — averaging $67.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$848
- Penumbra, Inc.$644
- Medtronic$376
- Boston Scientific$327
- Cook Incorporated$141
- Shockwave Medical, Inc$69
- plus $101 from 2 others
What the payments were for
- Grants$1416%
- Travel & lodging$30212%
- Food & beverage$1,80172%
- Education$26210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 11 | $848 |
| Penumbra, Inc. | 8 | $644 |
| Medtronic(2 entities) | 5 | $376 |
| Boston Scientific | 7 | $327 |
| Cook Incorporated | 1 | $141 |
| Shockwave Medical, Inc | 2 | $69 |
| Johnson & Johnson | 2 | $65 |
| Lemaitre Vascular, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,506 in reported general payments places this provider in the 50th percentile of 31 vascular surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,998 |
| Rosuvastatin Calcium | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Salt Lake City
- Craig SelzmanSalt Lake City$11K
- Thomas SerenaSalt Lake City$8K
- Holly RyanSalt Lake City$5K
- Benjamin BrookeSalt Lake City$4K
- Kaohinani LongwolfSalt Lake City$4K
- Alexander SchurmanSalt Lake City$4K
- Steven SimperSalt Lake City$2K
- Mark SarfatiSalt Lake City$1K
- Luke DegraaffSalt Lake City$881
- Larry KraissSalt Lake City$716
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.